Medical Plastic Compounds Comprehensive Study by Type (Polyvinylchloride, Polyethylene, Polypropylene, Polystyrene, Polyester, Polycarbonate, Polyurethane, Acrylics, Others), Application (Disposables, Catheters, Surgical Instruments, Medical Bags, Implants, Drug Delivery System, Others) Players and Region - Global Market Outlook to 2028

Medical Plastic Compounds Market by XX Submarkets | Forecast Years 2023-2028  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Medical Plastic Compounds Market Scope
Medical Plastic compounds are the basis of products, the global medical plastic market is segmented into Polypropylene (PP), Polyethylene (PE), Polycarbonate (PC), Liquid Crystal Polymer (LCP), Polyether sulfone (PES), polyethyleneimine (PEI), Polyphenol sulfone (PPSU), Polymethyl Methacrylate (PMMA), and others. Semi-crystalline polymers that are commonly used in the healthcare industry include polypropylene, polyethylene, nylon, and polyetheretherketone (PEEK).It is widely used in heart valve structure, urinary catheters, and disposable syringes owing to high chemical and bacterial resistance. Improved use of home health and self-medication devices is the market drives of medical plastic compound.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)
Key Companies ProfiledAmco Polymers (United States), Chroma Color Corporation (United States), Entec Polymers (United States), Monster Polymers (Canada), foster corporation (United States), Celanese Corp (United States), Arkema Sa(France), BASF SE(Germany ), Celanese Corp. (Texas) and Covestro Ag (Germany)
CAGR%


Medical Plastic Compounds is a fragmented market due to the presence of a large number of established competitors. The market is highly competitive with a few players occupying the major share. The key players are highly focused on developing and innovating new strategies to maintain their market position and customer base. The companies are also planning strategic activities like partnerships, collaboration, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge.

Amco Polymers (United States), Chroma Color Corporation (United States), Entec Polymers (United States), Monster Polymers (Canada), foster corporation (United States), Celanese Corp (United States), Arkema Sa(France), BASF SE(Germany ), Celanese Corp. (Texas) and Covestro Ag (Germany) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Evonik Industries Ag (Germany), ExxonMobil Corp. (United States), Royal Dsm (Netherlands), Solvay Sa (Belgium) and The Lubrizol Corp (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Medical Plastic Compounds market by Type , by Application (Disposables, Catheters, Surgical Instruments, Medical Bags, Implants, Drug Delivery System and Others) and Region with country level break-up.

On the basis of geography, the market of Medical Plastic Compounds has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2022.

Market Leaders and their expansionary development strategies
In August 2021,Benvic has acquired US-based Chemres, a provider of polymers, custom compounds and solutions for a variety of industries including medical. The acquisition of Chemres is the ninth ‘add-on’ acquisition since Benvic joined Invest industrial’s portfolio in 2018. Among the others, in 2019 Benvic acquired Modenplast Medical, an Italian compounder, specialising in medical-grade vinyl compounds and tubing extrusion., and In march 2023,Sterimed Group, through its UK subsidiary Westfield Medical, has announced that it has completed the acquisition of Grantown Medical, a manufacturer of sterilisation pouches and provider of packing services for the medical device industry in the UK.
In March 2023, Evonik, the market and innovation leader in polyurethane additives, has boosted its range of high-performance products for the spray polyurethane foam (SPF) industry with the release of DABCO PM 301. Used in combination with the latest Opteon™ 1100 and Opteon™ 1150 blowing agents from Chemours, a global chemistry company, DABCO PM 301 improves thermal performance and increases efficiency in SPF systems. and In August 2022, LEHVOSS high-performance compound plant goes into operation After extensive construction work in its innovation centre, the LEHVOSS Group has put another compounding plant into operation at its Hamburg location.


Influencing Trend:
Ecological and Environmental Concerns and Influence of the Consumer, Cost and Compatibility

Market Growth Drivers:
Improved use of home health and self-medication devices

Challenges:
Lack of trained professionals in healthcare

Restraints:
Raw material price volatility

Opportunities:
Increase in demand for plastics over metals

Key Target Audience
pharmaceutical companies, Biotechnological institutes, Government and private laboratories, Research and Development (R&D) companies, Medical research laboratories, Market research and consulting service providers, Government Agencies, End User Industry and Others

Report Objectives / Segmentation Covered

By Type
  • Polyvinylchloride
  • Polyethylene
  • Polypropylene
  • Polystyrene
  • Polyester
  • Polycarbonate
  • Polyurethane
  • Acrylics
  • Others
By Application
  • Disposables
  • Catheters
  • Surgical Instruments
  • Medical Bags
  • Implants
  • Drug Delivery System
  • Others
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Improved use of home health and self-medication devices
    • 3.3. Market Challenges
      • 3.3.1. Lack of trained professionals in healthcare
    • 3.4. Market Trends
      • 3.4.1. Ecological and Environmental Concerns and Influence of the Consumer
      • 3.4.2. Cost
      • 3.4.3. Compatibility
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Medical Plastic Compounds, by Type, Application and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Medical Plastic Compounds (Value)
      • 5.2.1. Global Medical Plastic Compounds by: Type (Value)
        • 5.2.1.1. Polyvinylchloride
        • 5.2.1.2. Polyethylene
        • 5.2.1.3. Polypropylene
        • 5.2.1.4. Polystyrene
        • 5.2.1.5. Polyester
        • 5.2.1.6. Polycarbonate
        • 5.2.1.7. Polyurethane
        • 5.2.1.8. Acrylics
        • 5.2.1.9. Others
      • 5.2.2. Global Medical Plastic Compounds by: Application (Value)
        • 5.2.2.1. Disposables
        • 5.2.2.2. Catheters
        • 5.2.2.3. Surgical Instruments
        • 5.2.2.4. Medical Bags
        • 5.2.2.5. Implants
        • 5.2.2.6. Drug Delivery System
        • 5.2.2.7. Others
      • 5.2.3. Global Medical Plastic Compounds Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Medical Plastic Compounds: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Amco Polymers (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Chroma Color Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Entec Polymers (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Monster Polymers (Canada)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Foster corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Celanese Corp (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Arkema Sa(France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. BASF SE(Germany )
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Celanese Corp. (Texas)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Covestro Ag (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Medical Plastic Compounds Sale, by Type, Application and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Medical Plastic Compounds (Value)
      • 7.2.1. Global Medical Plastic Compounds by: Type (Value)
        • 7.2.1.1. Polyvinylchloride
        • 7.2.1.2. Polyethylene
        • 7.2.1.3. Polypropylene
        • 7.2.1.4. Polystyrene
        • 7.2.1.5. Polyester
        • 7.2.1.6. Polycarbonate
        • 7.2.1.7. Polyurethane
        • 7.2.1.8. Acrylics
        • 7.2.1.9. Others
      • 7.2.2. Global Medical Plastic Compounds by: Application (Value)
        • 7.2.2.1. Disposables
        • 7.2.2.2. Catheters
        • 7.2.2.3. Surgical Instruments
        • 7.2.2.4. Medical Bags
        • 7.2.2.5. Implants
        • 7.2.2.6. Drug Delivery System
        • 7.2.2.7. Others
      • 7.2.3. Global Medical Plastic Compounds Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Medical Plastic Compounds: by Type(USD Million)
  • Table 2. Medical Plastic Compounds Polyvinylchloride , by Region USD Million (2017-2022)
  • Table 3. Medical Plastic Compounds Polyethylene , by Region USD Million (2017-2022)
  • Table 4. Medical Plastic Compounds Polypropylene , by Region USD Million (2017-2022)
  • Table 5. Medical Plastic Compounds Polystyrene , by Region USD Million (2017-2022)
  • Table 6. Medical Plastic Compounds Polyester , by Region USD Million (2017-2022)
  • Table 7. Medical Plastic Compounds Polycarbonate , by Region USD Million (2017-2022)
  • Table 8. Medical Plastic Compounds Polyurethane , by Region USD Million (2017-2022)
  • Table 9. Medical Plastic Compounds Acrylics , by Region USD Million (2017-2022)
  • Table 10. Medical Plastic Compounds Others , by Region USD Million (2017-2022)
  • Table 11. Medical Plastic Compounds: by Application(USD Million)
  • Table 12. Medical Plastic Compounds Disposables , by Region USD Million (2017-2022)
  • Table 13. Medical Plastic Compounds Catheters , by Region USD Million (2017-2022)
  • Table 14. Medical Plastic Compounds Surgical Instruments , by Region USD Million (2017-2022)
  • Table 15. Medical Plastic Compounds Medical Bags , by Region USD Million (2017-2022)
  • Table 16. Medical Plastic Compounds Implants , by Region USD Million (2017-2022)
  • Table 17. Medical Plastic Compounds Drug Delivery System , by Region USD Million (2017-2022)
  • Table 18. Medical Plastic Compounds Others , by Region USD Million (2017-2022)
  • Table 19. South America Medical Plastic Compounds, by Country USD Million (2017-2022)
  • Table 20. South America Medical Plastic Compounds, by Type USD Million (2017-2022)
  • Table 21. South America Medical Plastic Compounds, by Application USD Million (2017-2022)
  • Table 22. Brazil Medical Plastic Compounds, by Type USD Million (2017-2022)
  • Table 23. Brazil Medical Plastic Compounds, by Application USD Million (2017-2022)
  • Table 24. Argentina Medical Plastic Compounds, by Type USD Million (2017-2022)
  • Table 25. Argentina Medical Plastic Compounds, by Application USD Million (2017-2022)
  • Table 26. Rest of South America Medical Plastic Compounds, by Type USD Million (2017-2022)
  • Table 27. Rest of South America Medical Plastic Compounds, by Application USD Million (2017-2022)
  • Table 28. Asia Pacific Medical Plastic Compounds, by Country USD Million (2017-2022)
  • Table 29. Asia Pacific Medical Plastic Compounds, by Type USD Million (2017-2022)
  • Table 30. Asia Pacific Medical Plastic Compounds, by Application USD Million (2017-2022)
  • Table 31. China Medical Plastic Compounds, by Type USD Million (2017-2022)
  • Table 32. China Medical Plastic Compounds, by Application USD Million (2017-2022)
  • Table 33. Japan Medical Plastic Compounds, by Type USD Million (2017-2022)
  • Table 34. Japan Medical Plastic Compounds, by Application USD Million (2017-2022)
  • Table 35. India Medical Plastic Compounds, by Type USD Million (2017-2022)
  • Table 36. India Medical Plastic Compounds, by Application USD Million (2017-2022)
  • Table 37. South Korea Medical Plastic Compounds, by Type USD Million (2017-2022)
  • Table 38. South Korea Medical Plastic Compounds, by Application USD Million (2017-2022)
  • Table 39. Taiwan Medical Plastic Compounds, by Type USD Million (2017-2022)
  • Table 40. Taiwan Medical Plastic Compounds, by Application USD Million (2017-2022)
  • Table 41. Australia Medical Plastic Compounds, by Type USD Million (2017-2022)
  • Table 42. Australia Medical Plastic Compounds, by Application USD Million (2017-2022)
  • Table 43. Rest of Asia-Pacific Medical Plastic Compounds, by Type USD Million (2017-2022)
  • Table 44. Rest of Asia-Pacific Medical Plastic Compounds, by Application USD Million (2017-2022)
  • Table 45. Europe Medical Plastic Compounds, by Country USD Million (2017-2022)
  • Table 46. Europe Medical Plastic Compounds, by Type USD Million (2017-2022)
  • Table 47. Europe Medical Plastic Compounds, by Application USD Million (2017-2022)
  • Table 48. Germany Medical Plastic Compounds, by Type USD Million (2017-2022)
  • Table 49. Germany Medical Plastic Compounds, by Application USD Million (2017-2022)
  • Table 50. France Medical Plastic Compounds, by Type USD Million (2017-2022)
  • Table 51. France Medical Plastic Compounds, by Application USD Million (2017-2022)
  • Table 52. Italy Medical Plastic Compounds, by Type USD Million (2017-2022)
  • Table 53. Italy Medical Plastic Compounds, by Application USD Million (2017-2022)
  • Table 54. United Kingdom Medical Plastic Compounds, by Type USD Million (2017-2022)
  • Table 55. United Kingdom Medical Plastic Compounds, by Application USD Million (2017-2022)
  • Table 56. Netherlands Medical Plastic Compounds, by Type USD Million (2017-2022)
  • Table 57. Netherlands Medical Plastic Compounds, by Application USD Million (2017-2022)
  • Table 58. Rest of Europe Medical Plastic Compounds, by Type USD Million (2017-2022)
  • Table 59. Rest of Europe Medical Plastic Compounds, by Application USD Million (2017-2022)
  • Table 60. MEA Medical Plastic Compounds, by Country USD Million (2017-2022)
  • Table 61. MEA Medical Plastic Compounds, by Type USD Million (2017-2022)
  • Table 62. MEA Medical Plastic Compounds, by Application USD Million (2017-2022)
  • Table 63. Middle East Medical Plastic Compounds, by Type USD Million (2017-2022)
  • Table 64. Middle East Medical Plastic Compounds, by Application USD Million (2017-2022)
  • Table 65. Africa Medical Plastic Compounds, by Type USD Million (2017-2022)
  • Table 66. Africa Medical Plastic Compounds, by Application USD Million (2017-2022)
  • Table 67. North America Medical Plastic Compounds, by Country USD Million (2017-2022)
  • Table 68. North America Medical Plastic Compounds, by Type USD Million (2017-2022)
  • Table 69. North America Medical Plastic Compounds, by Application USD Million (2017-2022)
  • Table 70. United States Medical Plastic Compounds, by Type USD Million (2017-2022)
  • Table 71. United States Medical Plastic Compounds, by Application USD Million (2017-2022)
  • Table 72. Canada Medical Plastic Compounds, by Type USD Million (2017-2022)
  • Table 73. Canada Medical Plastic Compounds, by Application USD Million (2017-2022)
  • Table 74. Mexico Medical Plastic Compounds, by Type USD Million (2017-2022)
  • Table 75. Mexico Medical Plastic Compounds, by Application USD Million (2017-2022)
  • Table 76. Company Basic Information, Sales Area and Its Competitors
  • Table 77. Company Basic Information, Sales Area and Its Competitors
  • Table 78. Company Basic Information, Sales Area and Its Competitors
  • Table 79. Company Basic Information, Sales Area and Its Competitors
  • Table 80. Company Basic Information, Sales Area and Its Competitors
  • Table 81. Company Basic Information, Sales Area and Its Competitors
  • Table 82. Company Basic Information, Sales Area and Its Competitors
  • Table 83. Company Basic Information, Sales Area and Its Competitors
  • Table 84. Company Basic Information, Sales Area and Its Competitors
  • Table 85. Company Basic Information, Sales Area and Its Competitors
  • Table 86. Medical Plastic Compounds: by Type(USD Million)
  • Table 87. Medical Plastic Compounds Polyvinylchloride , by Region USD Million (2023-2028)
  • Table 88. Medical Plastic Compounds Polyethylene , by Region USD Million (2023-2028)
  • Table 89. Medical Plastic Compounds Polypropylene , by Region USD Million (2023-2028)
  • Table 90. Medical Plastic Compounds Polystyrene , by Region USD Million (2023-2028)
  • Table 91. Medical Plastic Compounds Polyester , by Region USD Million (2023-2028)
  • Table 92. Medical Plastic Compounds Polycarbonate , by Region USD Million (2023-2028)
  • Table 93. Medical Plastic Compounds Polyurethane , by Region USD Million (2023-2028)
  • Table 94. Medical Plastic Compounds Acrylics , by Region USD Million (2023-2028)
  • Table 95. Medical Plastic Compounds Others , by Region USD Million (2023-2028)
  • Table 96. Medical Plastic Compounds: by Application(USD Million)
  • Table 97. Medical Plastic Compounds Disposables , by Region USD Million (2023-2028)
  • Table 98. Medical Plastic Compounds Catheters , by Region USD Million (2023-2028)
  • Table 99. Medical Plastic Compounds Surgical Instruments , by Region USD Million (2023-2028)
  • Table 100. Medical Plastic Compounds Medical Bags , by Region USD Million (2023-2028)
  • Table 101. Medical Plastic Compounds Implants , by Region USD Million (2023-2028)
  • Table 102. Medical Plastic Compounds Drug Delivery System , by Region USD Million (2023-2028)
  • Table 103. Medical Plastic Compounds Others , by Region USD Million (2023-2028)
  • Table 104. South America Medical Plastic Compounds, by Country USD Million (2023-2028)
  • Table 105. South America Medical Plastic Compounds, by Type USD Million (2023-2028)
  • Table 106. South America Medical Plastic Compounds, by Application USD Million (2023-2028)
  • Table 107. Brazil Medical Plastic Compounds, by Type USD Million (2023-2028)
  • Table 108. Brazil Medical Plastic Compounds, by Application USD Million (2023-2028)
  • Table 109. Argentina Medical Plastic Compounds, by Type USD Million (2023-2028)
  • Table 110. Argentina Medical Plastic Compounds, by Application USD Million (2023-2028)
  • Table 111. Rest of South America Medical Plastic Compounds, by Type USD Million (2023-2028)
  • Table 112. Rest of South America Medical Plastic Compounds, by Application USD Million (2023-2028)
  • Table 113. Asia Pacific Medical Plastic Compounds, by Country USD Million (2023-2028)
  • Table 114. Asia Pacific Medical Plastic Compounds, by Type USD Million (2023-2028)
  • Table 115. Asia Pacific Medical Plastic Compounds, by Application USD Million (2023-2028)
  • Table 116. China Medical Plastic Compounds, by Type USD Million (2023-2028)
  • Table 117. China Medical Plastic Compounds, by Application USD Million (2023-2028)
  • Table 118. Japan Medical Plastic Compounds, by Type USD Million (2023-2028)
  • Table 119. Japan Medical Plastic Compounds, by Application USD Million (2023-2028)
  • Table 120. India Medical Plastic Compounds, by Type USD Million (2023-2028)
  • Table 121. India Medical Plastic Compounds, by Application USD Million (2023-2028)
  • Table 122. South Korea Medical Plastic Compounds, by Type USD Million (2023-2028)
  • Table 123. South Korea Medical Plastic Compounds, by Application USD Million (2023-2028)
  • Table 124. Taiwan Medical Plastic Compounds, by Type USD Million (2023-2028)
  • Table 125. Taiwan Medical Plastic Compounds, by Application USD Million (2023-2028)
  • Table 126. Australia Medical Plastic Compounds, by Type USD Million (2023-2028)
  • Table 127. Australia Medical Plastic Compounds, by Application USD Million (2023-2028)
  • Table 128. Rest of Asia-Pacific Medical Plastic Compounds, by Type USD Million (2023-2028)
  • Table 129. Rest of Asia-Pacific Medical Plastic Compounds, by Application USD Million (2023-2028)
  • Table 130. Europe Medical Plastic Compounds, by Country USD Million (2023-2028)
  • Table 131. Europe Medical Plastic Compounds, by Type USD Million (2023-2028)
  • Table 132. Europe Medical Plastic Compounds, by Application USD Million (2023-2028)
  • Table 133. Germany Medical Plastic Compounds, by Type USD Million (2023-2028)
  • Table 134. Germany Medical Plastic Compounds, by Application USD Million (2023-2028)
  • Table 135. France Medical Plastic Compounds, by Type USD Million (2023-2028)
  • Table 136. France Medical Plastic Compounds, by Application USD Million (2023-2028)
  • Table 137. Italy Medical Plastic Compounds, by Type USD Million (2023-2028)
  • Table 138. Italy Medical Plastic Compounds, by Application USD Million (2023-2028)
  • Table 139. United Kingdom Medical Plastic Compounds, by Type USD Million (2023-2028)
  • Table 140. United Kingdom Medical Plastic Compounds, by Application USD Million (2023-2028)
  • Table 141. Netherlands Medical Plastic Compounds, by Type USD Million (2023-2028)
  • Table 142. Netherlands Medical Plastic Compounds, by Application USD Million (2023-2028)
  • Table 143. Rest of Europe Medical Plastic Compounds, by Type USD Million (2023-2028)
  • Table 144. Rest of Europe Medical Plastic Compounds, by Application USD Million (2023-2028)
  • Table 145. MEA Medical Plastic Compounds, by Country USD Million (2023-2028)
  • Table 146. MEA Medical Plastic Compounds, by Type USD Million (2023-2028)
  • Table 147. MEA Medical Plastic Compounds, by Application USD Million (2023-2028)
  • Table 148. Middle East Medical Plastic Compounds, by Type USD Million (2023-2028)
  • Table 149. Middle East Medical Plastic Compounds, by Application USD Million (2023-2028)
  • Table 150. Africa Medical Plastic Compounds, by Type USD Million (2023-2028)
  • Table 151. Africa Medical Plastic Compounds, by Application USD Million (2023-2028)
  • Table 152. North America Medical Plastic Compounds, by Country USD Million (2023-2028)
  • Table 153. North America Medical Plastic Compounds, by Type USD Million (2023-2028)
  • Table 154. North America Medical Plastic Compounds, by Application USD Million (2023-2028)
  • Table 155. United States Medical Plastic Compounds, by Type USD Million (2023-2028)
  • Table 156. United States Medical Plastic Compounds, by Application USD Million (2023-2028)
  • Table 157. Canada Medical Plastic Compounds, by Type USD Million (2023-2028)
  • Table 158. Canada Medical Plastic Compounds, by Application USD Million (2023-2028)
  • Table 159. Mexico Medical Plastic Compounds, by Type USD Million (2023-2028)
  • Table 160. Mexico Medical Plastic Compounds, by Application USD Million (2023-2028)
  • Table 161. Research Programs/Design for This Report
  • Table 162. Key Data Information from Secondary Sources
  • Table 163. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Medical Plastic Compounds: by Type USD Million (2017-2022)
  • Figure 5. Global Medical Plastic Compounds: by Application USD Million (2017-2022)
  • Figure 6. South America Medical Plastic Compounds Share (%), by Country
  • Figure 7. Asia Pacific Medical Plastic Compounds Share (%), by Country
  • Figure 8. Europe Medical Plastic Compounds Share (%), by Country
  • Figure 9. MEA Medical Plastic Compounds Share (%), by Country
  • Figure 10. North America Medical Plastic Compounds Share (%), by Country
  • Figure 11. Global Medical Plastic Compounds share by Players 2022 (%)
  • Figure 12. Global Medical Plastic Compounds share by Players (Top 3) 2022(%)
  • Figure 13. Global Medical Plastic Compounds share by Players (Top 5) 2022(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Amco Polymers (United States) Revenue, Net Income and Gross profit
  • Figure 16. Amco Polymers (United States) Revenue: by Geography 2022
  • Figure 17. Chroma Color Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 18. Chroma Color Corporation (United States) Revenue: by Geography 2022
  • Figure 19. Entec Polymers (United States) Revenue, Net Income and Gross profit
  • Figure 20. Entec Polymers (United States) Revenue: by Geography 2022
  • Figure 21. Monster Polymers (Canada) Revenue, Net Income and Gross profit
  • Figure 22. Monster Polymers (Canada) Revenue: by Geography 2022
  • Figure 23. Foster corporation (United States) Revenue, Net Income and Gross profit
  • Figure 24. Foster corporation (United States) Revenue: by Geography 2022
  • Figure 25. Celanese Corp (United States) Revenue, Net Income and Gross profit
  • Figure 26. Celanese Corp (United States) Revenue: by Geography 2022
  • Figure 27. Arkema Sa(France) Revenue, Net Income and Gross profit
  • Figure 28. Arkema Sa(France) Revenue: by Geography 2022
  • Figure 29. BASF SE(Germany ) Revenue, Net Income and Gross profit
  • Figure 30. BASF SE(Germany ) Revenue: by Geography 2022
  • Figure 31. Celanese Corp. (Texas) Revenue, Net Income and Gross profit
  • Figure 32. Celanese Corp. (Texas) Revenue: by Geography 2022
  • Figure 33. Covestro Ag (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Covestro Ag (Germany) Revenue: by Geography 2022
  • Figure 35. Global Medical Plastic Compounds: by Type USD Million (2023-2028)
  • Figure 36. Global Medical Plastic Compounds: by Application USD Million (2023-2028)
  • Figure 37. South America Medical Plastic Compounds Share (%), by Country
  • Figure 38. Asia Pacific Medical Plastic Compounds Share (%), by Country
  • Figure 39. Europe Medical Plastic Compounds Share (%), by Country
  • Figure 40. MEA Medical Plastic Compounds Share (%), by Country
  • Figure 41. North America Medical Plastic Compounds Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Amco Polymers (United States)
  • Chroma Color Corporation (United States)
  • Entec Polymers (United States)
  • Monster Polymers (Canada)
  • foster corporation (United States)
  • Celanese Corp (United States)
  • Arkema Sa(France)
  • BASF SE(Germany )
  • Celanese Corp. (Texas)
  • Covestro Ag (Germany)
Additional players considered in the study are as follows:
Evonik Industries Ag (Germany) , ExxonMobil Corp. (United States) , Royal Dsm (Netherlands) , Solvay Sa (Belgium) , The Lubrizol Corp (United States)
Select User Access Type

Key Highlights of Report


Apr 2023 221 Pages 76 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Medical Plastic Compounds Market are by type [Polyvinylchloride, Polyethylene, Polypropylene, Polystyrene, Polyester, Polycarbonate, Polyurethane, Acrylics and Others], by end use application [Disposables, Catheters, Surgical Instruments, Medical Bags, Implants, Drug Delivery System and Others].
The Medical Plastic Compounds Market is gaining popularity and expected to see strong valuation by 2028.

Know More About Global Medical Plastic Compounds Report?